Apr 13, 2017 by Brian Orelli, PhDWhy ImmunoGen, Inc. Stock Jumped Higher TodayMomentum takes over the biotech's shares.
Apr 10, 2017 by Brian Orelli, PhDWhy Oncomed Pharmaceuticals Inc. Got Slaughtered TodayA failed clinical trial and a lost partner make for a bad Monday.
Apr 6, 2017 by Brian Orelli, PhDThe First CAR-T Drugs Have Left the GateInvestors should keep an eye on this promising way to treat cancer.
Apr 6, 2017 by Brian Orelli, PhDWhy FibroGen Inc Popped Higher TodayThe biotech makes a stock offering at a good price.
Apr 3, 2017 by Brian Orelli, PhDWhy Acorda Therapeutics Inc Plummeted for a Second Straight DayAfter losing a patent battle, an analyst downgrades the biotech.
Mar 31, 2017 by Brian Orelli, PhDWhy Acorda Therapeutics Inc and Forward Pharma A/S Got Crushed TodayPatent battles end poorly for both companies.
Mar 30, 2017 by Brian Orelli, PhDThe 3 Best Cholesterol Drug Stocks to Buy in 2017Investors should benefit from these biotechs' cholesterol drugs.
Mar 30, 2017 by Brian Orelli, PhDWhy "Positive" Data Knocked Down Corbus Pharmaceuticals Holdings Inc TodayIn biotech, the devil is often in the details.
Mar 28, 2017 by Brian Orelli, PhDIonis Pharmaceuticals Inc. Doesn't Want to Sell Drugs (Just Profit From Them)The biotech plans to spin off its lead unpartnered drug into a separate company.
Mar 20, 2017 by Brian Orelli, PhDWhy Aevi Genomic Medicine Got Crushed TodayThe biotech's share price was cut in half after the company announced a failed clinical trial for its lead drug.
Mar 16, 2017 by Brian Orelli, PhDWhy Ocular Therapeutix Inc Saw its Share Price Jump TodayPositive patient experience for the company's eye insert, Dextenza, sends shares higher.
Mar 16, 2017 by Brian Orelli, PhD3 Numbers That Make Gilead Sciences, Inc. Look Cheaper Than It Really IsBut this value trap does have one big thing going for it.
Mar 14, 2017 by Brian Orelli, PhDWhy Lantheus Holdings Inc. Got Smacked Down TodayA large shareholder is liquidating some of its shares.
Mar 13, 2017 by Brian Orelli, PhDWhy Aralez Pharmaceuticals Inc. Got Slaughtered TodayFourth-quarter earnings and guidance for 2017 were not what the doctor ordered.
Mar 13, 2017 by Brian Orelli, PhDCantel Medical Corp. Posts Double-Digit Growth Across the BoardThe medical supply company continues toward its goal of doubling sales and profits over the next five years.
Mar 9, 2017 by Brian Orelli, PhDWhy Immunomedics, Inc. Jumped Higher TodayInvestors are hoping for a better deal for IMMU-132.
Mar 8, 2017 by Brian Orelli, PhDWhy Global Blood Therapeutics Rocketed Higher TodayA potential acquisition sends the biotech's shares higher.
Mar 7, 2017 by Brian Orelli, PhDWhy Akebia Therapeutics Inc. Tanked TodayThe development-stage biotech saw investors get skittish, and the reason may be that some of them hadn't done their homework.
Mar 4, 2017 by Brian Orelli, PhDAbout to Buy Marijuana Stocks? Read This FirstThere are right and wrong ways to invest in the marijuana industry.
Mar 2, 2017 by Brian Orelli, PhDWhy Juno Therapeutics Inc. Tanked on ThursdayThe biotech ditches its lead therapeutic candidate.
